Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Epithelial Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Early research (Phase 1)Ended earlyNCT01177501
What this trial is testing

Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian Carcinoma

Who this might be right for
Ovarian CancerRelapses
Assistance Publique - Hôpitaux de Paris 3
Testing effectiveness (Phase 2)Ended earlyNCT03622931
What this trial is testing

Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines

Who this might be right for
Ovarian Cancer
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21
Testing effectiveness (Phase 2)Ended earlyNCT01137071
What this trial is testing

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Recepta Biopharma 29
Testing effectiveness (Phase 2)UnknownNCT04015739
What this trial is testing

Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse

Who this might be right for
Epithelial Ovarian CancerRelapse
ARCAGY/ GINECO GROUP 74
Testing effectiveness (Phase 2)Study completedNCT00189566
What this trial is testing

Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse

Who this might be right for
Ovarian CancerFallopian Tube CancerMalignant Tumor of Peritoneum
ARCAGY/ GINECO GROUP 165
Testing effectiveness (Phase 2)Study completedNCT00316407
What this trial is testing

Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients

Who this might be right for
Ovarian Epithelial Cancer Stage IIIStage IV Ovarian CancerStage IV Breast Cancer
Swedish Medical Center 30
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Not applicableWithdrawnNCT00898612
What this trial is testing

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Lymphoma
Mayo Clinic
Testing effectiveness (Phase 2)WithdrawnNCT01624493
What this trial is testing

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
Hoosier Cancer Research Network
Early research (Phase 1)Study completedNCT01940172
What this trial is testing

Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer

Who this might be right for
Relapsed Epithelial Ovarian CancerRelapsed Primary Peritoneal CancerRelapsed Fallopian Tube Cancer
TetraLogic Pharmaceuticals 27
Testing effectiveness (Phase 2)Study completedNCT03657966
What this trial is testing

DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer Recurrent
SOTIO a.s. 33
Testing effectiveness (Phase 2)Study completedNCT00710762
What this trial is testing

A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Boehringer Ingelheim 89
Not applicableStudy completedNCT00538603
What this trial is testing

Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)

Who this might be right for
Epithelial Ovarian Cancer
King Faisal Specialist Hospital & Research Center 8
Not applicableLooking for participantsNCT06232213
What this trial is testing

Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Model

Who this might be right for
Personalized Cancer Treatment
Hua Li 40
Not applicableUnknownNCT06037213
What this trial is testing

A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib

Who this might be right for
Ovarian Cancer
Peking Union Medical College Hospital 500
Very early researchUnknownNCT03799913
What this trial is testing

MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zhejiang University 20
Testing effectiveness (Phase 2)Study completedNCT00090610
What this trial is testing

Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer

Who this might be right for
Ovarian Cancer
Duke University 150
Large-scale testing (Phase 3)Study completedNCT01968213
What this trial is testing

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
pharmaand GmbH 564
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Next Page